Article: ETBOND TECHNOLOGYTM Defines Biotechnology Approach for Global Healthcare Reform.

ETBOND TECHNOLOGY defines Biotechnology approach to fight H1N1 Influenza A (Swine Flu) 1. Plan for Morbidity Reduction: H1N1 Influenza A (Swine Flu and its symptoms) is spreading at a lightening speed globally. It is infecting millions of patients since first reported in April, 2009 in Mexico. Costly quarantine and control measures are in place to prevent the spread of the disease from patients to family and contacts in public places. ETBOND TECHNOLOGY TM Plan: Since the much of spread occur through nasal route, ET 007 SWF is a Biotechnology drug that has been developed to reduce entry and fusion of Influenza A, 2009 (Swine Flu). The drug is assigned a Pre-IND number by ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!